Navigation Links
Results From Investigator-Sponsored Trials Presented at SSIEM Conference
Date:9/1/2010

Response to treatment can only be determined by a therapeutic trial of Kuvan.

Kuvan has not been studied in patients with liver or renal impairment. Patients who have these conditions should be carefully monitored when receiving Kuvan. Caution should be used with the administration of Kuvan to patients who are receiving levodopa and drugs that affect nitric oxide–mediated vasorelaxation or folate metabolism.

The most serious adverse reactions reported during Kuvan administration (regardless of relationship to treatment) were gastritis, spinal cord injury, streptococcal infection, testicular carcinoma, and urinary tract infection. Mild to moderate neutropenia was also noted. The most common adverse reactions were headache, diarrhea, abdominal pain, upper respiratory tract infection, pharyngolaryngeal pain, vomiting, and nausea.

About PKUPKU, a genetic disorder affecting approximately 50,000 diagnosed patients in the developed world, is caused by a deficiency of the enzyme phenylalanine hydroxylase (PAH). PAH is required for the metabolism of phenylalanine, an essential amino acid found in most protein-containing foods. If the active enzyme is not present in sufficient quantities, Phe accumulates to abnormally high levels in the blood and becomes toxic to the brain, resulting in a variety of complications including severe mental retardation and brain damage, mental illness, seizures, tremors, and limited cognitive ability. As a result of newborn screening efforts implemented in the 1960s and early 1970s, virtually all PKU patients under the age of 40 in developed countries have been diagnosed at birth. To learn more about PKU, please visit www.PKU.com. Information on this website is not incorporated by reference into this press release.

About BioMarinBioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. The company's product portfolio com
'/>"/>

SOURCE BioMarin Pharmaceutical Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Proprietary Zinc/Phytase Formulation Improved Botulinum Toxin A Results
2. Accuray Announces Results for Fourth Quarter and Fiscal Year 2010
3. CORDIS Announces Results of Ten-Year CYPHER(R) Sirolimus-Eluting Coronary Stent Follow-Up
4. Unilife Corporation Announces Preliminary Financial Results for Fourth Quarter and Fiscal Year 2010
5. Cyberonics Reports Strong Fiscal 2011 First Quarter Results
6. Preliminary Research Results Suggest up to 70% Reduction in Dose for Positron Emission Mammography Imaging
7. Topline Results From Phase 3 Trial of Sunitinib With Erlotinib in Advanced Non-Small Cell Lung Cancer (NSCLC)
8. MedClean Technologies Announces Second Quarter Results
9. Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2010 Financial Results
10. Huifeng Bio-Pharmaceutical Reported Second Quarter 2010 Financial Results and Reaffirms its 2010 Guidance
11. China Yongxin Pharmaceuticals Reports Second Quarter 2010 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... , Sept. 19, 2014  Lpath, Inc. ... in bioactive lipid-targeted therapeutics, announced today that it ... registered shares of common stock and 3,605,042 unregistered ... purchase price for one registered share of common ... unregistered share of common stock will be $3.475.  ...
(Date:9/19/2014)...  Over 200 runners participated in the fifth annual ... Oncology Institute (ROI), hosted by Radiation Business Solutions. This year ... San Francisco.  "Donations are still coming ... Business Solutions, "but at this point, through registrations ... the ROI this year. This surpasses last year,s record ...
(Date:9/19/2014)... 19, 2014 Reductions in kidney ... years in people with diabetes type 2 ... benefits for the kidneys." Australian researchers have ... 2 diabetes leads to persistent reductions in kidney failure ... The global study has found that, five and a ...
Breaking Medicine Technology:Lpath, Inc. Announces $12.5 Million Registered Direct Offering 2Lpath, Inc. Announces $12.5 Million Registered Direct Offering 3Fifth Annual 5K Run for the Future to Benefit the Radiation Oncology Institute Breaks Attendance, Donation Records 2Fifth Annual 5K Run for the Future to Benefit the Radiation Oncology Institute Breaks Attendance, Donation Records 3ADVANCE-ON Post-trial Observational Study: Blood Pressure Arm and Glucose Arm Results 2ADVANCE-ON Post-trial Observational Study: Blood Pressure Arm and Glucose Arm Results 3
... Nov. 12, 2010 Cephalon, Inc. (Nasdaq: CEPH ) ... to be held on November 18, 2010, will be webcast ... www.cephalon.com . Cephalon,s senior management will ... development initiatives.  The presentation will be delivered on Thursday, November ...
... 12, 2010 Royal Philips Electronics (NYSE: PHG, AEX: ... research fellow at the Cerebral Vascular Disease Research Center, ... Medicine, has been selected as the recipient of the ... The $100,000 grant, which is funded over a ...
Cached Medicine Technology:Cephalon to Webcast Investor Day 2Philips and American Heart Association Present Fourth Annual Resuscitation Fellowship Award 2
(Date:9/20/2014)... iFitDress.com, the popular online supplier of wedding dresses and ... new collection of cocktail gowns. This afternoon, the company ... new outfits; it intends to expand its online market ... cheap cocktail dresses in the company’s online ... extensive experience in the industry of women’s special occasion ...
(Date:9/20/2014)... September 20, 2014 "As a nurse, patients ... tanks," said an inventor from Tamaqua, Pa. "The reason that ... the backs of their chairs. My invention enables them to ... Kam Oxygen Sensor to make it easier to monitor the ... user knows when the tank is low. It allows changeovers ...
(Date:9/20/2014)... QueenBeeTickets.com is ready to offer discount Ariana Grande ... visit many cities in North America next year from ... , Click Here to view the inventory ... The star’s fans are not going to want to ... in a live performance. Ariana Grande concert tickets are ...
(Date:9/20/2014)... OH (PRWEB) September 20, 2014 The ... lawsuit is now in its third week in the ... Schulte LLC reports. Court documents indicate that the week ... with testimony from a DePuy Orthopaedics vice president, ... version of the company’s Pinnacle hip replacement. According to ...
(Date:9/19/2014)... OH (PRWEB) September 20, 2014 Nearly ... Court of Common Pleas where a meeting took place ... side-effects complaints pending in the court’s mass tort ... to meet this past week at the Complex Litigation ... are consolidated for pretrial proceedings. The Risperdal lawsuits filed ...
Breaking Medicine News(10 mins):Health News:Fashionable Cocktail Dresses Unveiled Online at iFitDress.com 2Health News:Discount Ariana Grande Tickets: QueenBeeTickets.com Delights Fans with Discount Concert Tickets for Ariana Grande’s 2015 Honeymoon Tour 2Health News:Third Week of DePuy Pinnacle Hip Lawsuit Trial Focuses on Clinical Testing of Metal-on-Metal Hip Implant, Wright & Schulte LLC Reports 2Health News:Third Week of DePuy Pinnacle Hip Lawsuit Trial Focuses on Clinical Testing of Metal-on-Metal Hip Implant, Wright & Schulte LLC Reports 3Health News:Third Week of DePuy Pinnacle Hip Lawsuit Trial Focuses on Clinical Testing of Metal-on-Metal Hip Implant, Wright & Schulte LLC Reports 4Health News:Risperdal Lawsuits Move Forward As Attorneys Meet To Discuss Litigation, Reports Wright & Schulte LLC 2Health News:Risperdal Lawsuits Move Forward As Attorneys Meet To Discuss Litigation, Reports Wright & Schulte LLC 3Health News:Risperdal Lawsuits Move Forward As Attorneys Meet To Discuss Litigation, Reports Wright & Schulte LLC 4
... PROVIDENCE, RI Does obesity tend to "cluster" among ... have on both their weight and weight-related behaviors? That,s ... Diabetes Research Center set out to answer to better ... weight loss intentions in this difficult-to-reach age group. ...
... According to the World Health Organization (WHO), chronic diseases are ... representing 60% of all deaths worldwide and imposing an enormous ... whole. With its ageing population, Europe is bracing ... next decade. "We are pleased that the Council ...
... of an ectopic pregnancy because of a lasting effect of ... first time of how chlamydia can increase the risk of ... outside the womb, in the Fallopian tube. Researchers at ... the sexually transmitted infection were more likely to produce a ...
... January 2011: With its spotlight theme of ,Controversial ... Society of Cardiology (ESC) Congress promises lively discussions and ... as the world,s premier cardiovascular conference and regularly attracts ... through its doors. It will be held this ...
... By Steven Reinberg HealthDay Reporter , MONDAY, Jan. 10 ... in front of a computer may increase your risk for heart ... In fact, if you spend four hours a day or ... playing video games, you are more than two times more likely ...
... 11 (HealthDay News) -- Intensive care unit (ICU) patients in ... shared rooms, a new study finds. About 30 percent ... lead to serious illness and death, the study authors noted ... these infections are associated with an increased length of stay ...
Cached Medicine News:Health News:Family, friends, social ties influence weight status in young adults 2Health News:A new era for chronic diseases in Europe? 2Health News:Countdown to Paris and ESC Congress 2011 2Health News:Countdown to Paris and ESC Congress 2011 3Health News:Too Much TV May Be Linked to Heart Attack, Death Risk 2Health News:Too Much TV May Be Linked to Heart Attack, Death Risk 3Health News:Private Rooms Cut Infection Risk in the ICU: Study 2
The UNI_CLIP® is a reliable and stable compression staple....
... Indications include painful arthritic deformity ... in the subtalar joint, failed fusion ... the tibial plafond and/or talus where ... the ankle joint combined with severe ...
... System from DePuy is the first total ... of support that bridges the fused tibiofibular ... distribution. The Agility Ankle, developed in conjunction ... allow for normal alignment during the stance ...
... the key clinical and economic issues of ... is designed to maximize tension control while ... system combines efficient instrumentation with a simple ... system is indicated for general orthopaedic trauma ...
Medicine Products: